Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative EMDA Mitomycin-C for NMIBC
NCT01149174Phase 3Completed
- Sponsor
- University of Rome Tor Vergata
- Start
- Jan 1994
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in non-muscle-invasive bladder cancer (NMIBC), sponsored by University of Rome Tor Vergata. Started Jan 1994; status: completed.
02
Drugs
mitomycin c
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT01149174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149174.